These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8201246)

  • 1. The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders.
    Salomon RM; Miller HL; Delgado PL; Charney D
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():41-6. PubMed ID: 8201246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of norepinephrine in depression.
    Delgado PL; Moreno FA
    J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants and the brain.
    Delgado P; Moreno F
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 1():S9-16. PubMed ID: 10468323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mood-lowering effect of tryptophan depletion: possible explanation for discrepant findings.
    Van der Does AJ
    Arch Gen Psychiatry; 2001 Feb; 58(2):200-2. PubMed ID: 11177123
    [No Abstract]   [Full Text] [Related]  

  • 7. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ; McTavish SF; Park SB; Cowen PJ
    Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors.
    Moore P; Gillin C; Bhatti T; DeModena A; Seifritz E; Clark C; Stahl S; Rapaport M; Kelsoe J
    Arch Gen Psychiatry; 1998 Jun; 55(6):534-9. PubMed ID: 9633672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
    Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
    CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin dysfunction disorders: a behavioral neurochemistry perspective.
    Petty F; Davis LL; Kabel D; Kramer GL
    J Clin Psychiatry; 1996; 57 Suppl 8():11-6. PubMed ID: 8698675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin transporter: a primary target for antidepressant drugs.
    Schloss P; Williams DC
    J Psychopharmacol; 1998; 12(2):115-21. PubMed ID: 9694022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.
    Bradley AJ; Lenox-Smith AJ
    J Psychopharmacol; 2013 Aug; 27(8):740-58. PubMed ID: 23832963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of tryptophan/large neutral amino acids ratio to antidepressant response.
    Lucini V; Lucca A; Catalano M; Smeraldi E
    J Affect Disord; 1996 Jan; 36(3-4):129-33. PubMed ID: 8821315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.
    Bremner JD; Vythilingam M; Ng CK; Vermetten E; Nazeer A; Oren DA; Berman RM; Charney DS
    JAMA; 2003 Jun; 289(23):3125-34. PubMed ID: 12813118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.